A

AffyXell Therapeutics, Co., Ltd.

6 employees

AffyXell Therapeutics develops novel mesenchymal stem cell therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cell and gene
Stem cell
Therapeutics
autoimmune diseases
orphan diseases
Immunetolerance
Immune disorders

Date founded

2020

Funding rounds raised

Total raised

$7.2M

from 3 investors over 3 rounds

A

AffyXell Therapeutics, Co., Ltd. raised undisclosed on April 13, 2022

Investors: Avacta Analytical

A

AffyXell Therapeutics, Co., Ltd. raised $7.2M on February 1, 2021

Investors: Smilegate Investment and Samsung Venture Investment

FAQ